Handelsbanken Fonder AB - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2021$626,000
-6.8%
17,1000.0%0.00%
-25.0%
Q2 2021$672,000
+96.5%
17,100
+41.3%
0.00%
+100.0%
Q1 2021$342,000
-11.6%
12,1000.0%0.00%0.0%
Q4 2020$387,000
-1.0%
12,1000.0%0.00%
-33.3%
Q3 2020$391,000
-16.5%
12,100
-28.8%
0.00%
+50.0%
Q2 2020$468,00017,0000.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders